[铁蛋白、癌胚抗原和催乳素的放射免疫分析用于评估乳腺癌治疗的预后和疗效]
[Radioimmunologic analysis of ferritin, carcinoembryonic antigen and prolactin for evaluating the prognosis and effectiveness of treating breast cancer].
作者信息
Skliar S Iu, Chebotareva E D, Ganul V L, Korolev V I
出版信息
Med Radiol (Mosk). 1987 Oct;32(10):32-6.
PMID:3657434
Abstract
The levels of tumor markers--CEA, ferritin and prolactin (the hormone of the anterior pituitary gland) were studied in the blood serum of 178 breast cancer patients in the menopause during combined therapy using a radioimmunoassay. This combination was shown to be informative for assessment of prognosis of disease and efficacy of antitumor therapy which was confirmed by clinical and x-ray findings and observation of a tumor process in breast cancer patients over a 5-year period.
摘要
采用放射免疫分析法，对178例绝经后乳腺癌患者在联合治疗期间血清中的肿瘤标志物——癌胚抗原（CEA）、铁蛋白和催乳素（垂体前叶激素）水平进行了研究。临床和X线检查结果以及对乳腺癌患者肿瘤进程长达5年的观察证实，这种联合检测对于评估疾病预后和抗肿瘤治疗效果具有指导意义。
相似文献
1
2
3
[Tumor markers in the diagnosis and prognosis of breast cancer].[肿瘤标志物在乳腺癌诊断和预后中的应用]
Klin Med (Mosk). 1993;71(2):25-7.
4
5
Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
J Postgrad Med. 1996 Jul-Sep;42(3):68-71.
6
[Serum marker changes during the rehabilitative treatment of stomach cancer patients].[胃癌患者康复治疗期间的血清标志物变化]
Vopr Onkol. 1990;36(2):167-71.
7
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.癌胚抗原（CEA）作为乳腺癌血清标志物的重新评估：一项前瞻性纵向研究。
Clin Cancer Res. 2001 Aug;7(8):2357-62.
8
[Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].[TPS、CA153和CEA联合检测在乳腺癌中的诊断价值]
Di Yi Jun Yi Da Xue Xue Bao. 2005 Oct;25(10):1293-4, 1298.
9
The usefulness of serum levels of CEA, CA 50, and ferritin in the management of renal cell cancer.
J Environ Pathol Toxicol Oncol. 1996;15(2-4):279-81.
10
Breast cancer and tumor markers.乳腺癌与肿瘤标志物。
J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):43-7.
Zotero 插件